Provided by Tiger Trade Technology Pte. Ltd.

REMEGEN

80.450
-3.350-4.00%
Volume:2.06M
Turnover:166.49M
Market Cap:45.34B
PE:53.47
High:83.600
Open:82.050
Low:79.700
Close:83.800
52wk High:126.600
52wk Low:63.300
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:0.60
T/O Rate:0.99%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.505
ROE:109.10%
ROA:39.01%
PB:4.68
PE(LYR):53.47
PS:4.86

Loading ...

RemeGen Invests $70 Million in Financial Product from OCBC

Stock News
·
May 14

RemeGen Announces Acquisition of 1.43 Billion Yuan in Bank Wealth Management Products

Stock News
·
May 13

HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%

Tiger Newspress
·
May 11

Stock Track | REMEGEN Plummets 5.12% Intraday on Lock-up Expiry Fears, Weak Earnings, and Sector Weakness

Stock Track
·
May 11

Stock Track | REMEGEN Plummets 6.51% Intraday on Sharp Q1 Profit Decline and Biotech Sector Weakness

Stock Track
·
May 04

RemeGen Q1 Profit Of ¥328m Revives Bullish Narratives On Biotech Turnaround

Simply Wall St.
·
Apr 29

RemeGen Swings to Profit in Q1 2026

MT Newswires Live
·
Apr 29

REMEGEN Turns Profitable in Q1 2026 on 24.8% Sales Growth and Sharply Lower R&D Spend

Bulletin Express
·
Apr 28

RemeGen 2025 ESG Report: Energy Intensity Cut by 49%, R&D Investment Reaches RMB1.22 Billion

Bulletin Express
·
Apr 28

荣昌生物2025年实现业绩显著扭转 净利达7.10亿元 营收同比增长89.5%

Bulletin Express
·
Apr 28

HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%

Tiger Newspress
·
Apr 28

Huitianfu Fund Increases Stake in REMEGEN by 79,000 Shares at HK$113.78 Per Share

Stock News
·
Apr 24

Biopharma Stocks Slide Across Board as Oil Prices Squeeze Rate Cut Prospects

Stock News
·
Apr 23

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress
·
Apr 23

Stock Track | REMEGEN Plummets 5.19% Intraday as Profit-Taking Follows Fully Priced-In Catalysts

Stock Track
·
Apr 23

Profitability Reaches 17 Biotech Firms Including BeiGene, Innovent, Beta Pharma, and Remegen

Deep News
·
Apr 21

Why RemeGen (SEHK:9995) Is Up 13.1% After First HER2 ADC–Immunotherapy Approval in China

Simply Wall St.
·
Apr 18

RemeGen Schedules 28 April 2026 Board Meeting to Review Q1 2026 Unaudited Results

Bulletin Express
·
Apr 16

CATL Reports 48.52% Surge in Q1 Net Profit to RMB 20.74 Billion

Stock News
·
Apr 16

National Data Administration Proposes Token Trading Exploration; Central Bank Adjusts Overseas Loan Ratios

Stock News
·
Apr 16